Tevogen TVGN
NASDAQ TVGN
$6.72 +0.10 (+1.51%)
As of: Oct 1, 2026 · 3:26 PM EDT

Tevogen (TVGN) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Tevogen (TVGN) posted Liabilities and Shareholders Equity of $4.92 million for Q1 2026, up 20.8% from $4.07 million a year earlier and up 12.3% from the prior quarter.

Analysis

Tevogen (TVGN) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Tevogen's Liabilities and Shareholders Equity came in at $4.38 million, up 26.6% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a four-year compound annual growth rate of -66.6% (FY2021 to FY2025).
  • In prior years, Tevogen's Liabilities and Shareholders Equity was $3.46 million in FY2024 (-37.1%), $5.51 million in FY2023 (-98.5%), $357.14 million in FY2022 (+1.2%) and $352.85 million in FY2021.
  • The Q1 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity since Q4 2023.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last five quarters, with an average decline of 13.3% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q2 2025, with growth of 29.0%; the weakest was Q4 2023, with a decline of 98.5%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $4.38 million (Q4 2025), $4.49 million (Q3 2025) and $4.27 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Tevogen 27.60 Mn 24.63 Mn - 4.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.92 Mn
Dec 31, 2025 4.38 Mn
Sep 30, 2025 4.49 Mn
Jun 30, 2025 4.27 Mn
Mar 31, 2025 4.07 Mn
Dec 31, 2024 3.46 Mn
Sep 30, 2024 4.29 Mn
Jun 30, 2024 3.31 Mn
Mar 31, 2024 3.36 Mn
Dec 31, 2023 5.51 Mn
Sep 30, 2023 26.41 Mn
Jun 30, 2023 26.38 Mn
Mar 31, 2023 25.47 Mn
Dec 31, 2022 357.14 Mn
Sep 30, 2022 354.54 Mn
Jun 30, 2022 352.98 Mn
Mar 31, 2022 352.83 Mn
Dec 31, 2021 352.85 Mn
API Access

Tevogen Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TVGN&period=max&api_key=YOUR_API_KEY